Dr Paul Appelbaum New York City, NY - 10027

Dr Paul Appelbaum is categorized under Specialty Outpatient Clinics, Nec in New York City, NY and active since 2007.

Dr Paul Appelbaum was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 621498 by the NAICS.

If you are seeking more information, feel free to contact Dr Paul Appelbaum at the company’s single location by writing to 39 Claremont Avenue Apartment 24, New York City, New York NY 10027 or by phoning (212) 866-6701. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr Paul Appelbaum
Contact Person: Dr Paul Appelbaum
Address: 39 Claremont Avenue Apartment 24, New York City, New York 10027
Phone Number: (212) 866-6701
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Specialty Outpatient Clinics, Nec
SIC Code: 8093
NAICS Code: 621498
Share This Business:

Dr Paul Appelbaum was started in 2007 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dr Paul Appelbaum for inquiries that concern Dr Paul Appelbaum by calling the company number (212) 866-6701, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Paul Appelbaum can be found at the coordinates 40.809962,-73.963976 as well as the street address 39 Claremont Avenue Apartment 24 in New York City, New York 10027.

For its online presence, you may visit Dr Paul Appelbaum’s website at and engage with its social media outlets through on Twitter and on Facebook.